Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e1030faa01a2482e160624b3f9dfdc0 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87612ba9119343a20b567fe1f33c0374 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e0051c8ba71b1910633fbbf2713395c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32a63b1cbc35a0bb78d9e677061ad1db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c970aaf81d9ff3765dc15239c1cc285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb691f1087c87239bc87e58168dd22d0 |
publicationDate |
2021-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021292334-A1 |
titleOfInvention |
Triazolotriazine derivatives as a2a receptor antagonists |
abstract |
The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyperfunctioning, such as certain types cancers. Compounds of formula (1) and methods of preparing the compounds are disclosed in the invention. |
priorityDate |
2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |